How have OCPNY shares performed in 2024?

Olympus' stock was trading at $18.00 at the beginning of the year. Since then, OCPNY stock has increased by 0.0% and is now trading at $18.00. View the best growth stocks for 2024 here .

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) posted its quarterly earnings results on Thursday, August, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.03. The company earned $1.75 billion during the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a net margin of 13.80% and a trailing twelve-month return on equity of 24.30%.

Is Olympus a good dividend stock?

Olympus (OTCMKTS:OCPNY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, OCPNY will have a dividend payout ratio of 9.20% next year. This indicates that the company will be able to sustain or increase its dividend.

How do I buy shares of Olympus?

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Olympus have any subsidiaries?

The following companies are subsidiares of Olympus: AIZU OLYMPUS CORPORATION, ALGRAM GROUP LIMITED, AOMORI OLYMPUS CO. LTD., ARC MEDICAL DESIGN LIMITED, Advalytix AG, Arc Medical Design Limited, EVIDENT CORPORATION, EVIDENT NAGANO K.K., EVIDENT SCIENTIFIC SINGAPORE PTE. LTD., Evident Europe GmbH, Evident Europe GmbH - odštepný závod, Evident Europe GmbH Közvetlen Kereskedelmi Képviselete, Evident Europe GmbH Suomen sivuliike, Evident Korea Co. Ltd., Evident Scientific S. de R.L. de C.V., Evident Service Center Europe s.r.o., Evident Technology Center Europe GmbH, FH ORTHO, FH ORTHO SAS, FOURNITURES HOSPITALIERES INDUSTRIE, GYRUS MEDICAL LIMITED, Gyrus Acmi L.P., Gyrus Acmi LLC, Gyrus Ent L.L.C., Image Stream Medical Inc, Innov-X Systems Inc., KEYMED (IRELAND) LIMITED, KEYMED (MEDICAL & INDUSTRIAL EQUIPMENT) LIMITED, NAGANO OLYMPUS CO. LTD., OLIMPAS MOSKVA OOO, OLYMPUS (MALAYSIA) SDN. BHD., OLYMPUS (THAILAND) COMPANY LIMITED, OLYMPUS BUSINESS SERVICES SP Z O O, OLYMPUS DIGITAL SYSTEM DESIGN CORP., OLYMPUS ESTONIA OU, OLYMPUS EUROPA HOLDING SE, OLYMPUS GLOBAL TREASURY SERVICES LIMITED, OLYMPUS IBERIA SA., OLYMPUS IMAGING SINGAPORE PTE. LTD., OLYMPUS KEYMED GROUP LIMITED, OLYMPUS KEYMED INTERNATIONAL LIMITED, OLYMPUS MARKETING INC., OLYMPUS MEDICAL SYSTEMS CORP., OLYMPUS MEDICAL SYSTEMS VIETNAM CO. LTD, OLYMPUS OPTICAL TECHNOLOGY PHILIPPINES INC., OLYMPUS POLSKA SP Z O O, OLYMPUS SINGAPORE PTE. LTD., OLYMPUS SUPPORT MATE K.K., OLYMPUS TAIWAN CO. LTD., OLYMPUS TECHNOLOGIES SINGAPORE PTE LTD, OLYMPUS TERUMO BIOMATERIALS CORP., OLYMPUS VIET NAM COMPANY LIMITED, OLYMPUS Winter & Ibe GmbH, Olympus America Inc., Olympus América de México S.A. de C.V., Olympus Australia Pty Ltd, Olympus Austria Gesellschaft m.b.H., Olympus Belgium, Olympus Biotech Corporation, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group, Olympus Czech Group Podruznica Ljubljana, Olympus Czech Group s.r.o. Magyarországi Közvetlen Kereskedelmi Képviselete, Olympus Czech Group s.r.o. clen koncernu, Olympus Czech Group s.r.o. clen koncernu organizacná zložka, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Europa Management SE, Olympus Europa Property Management GmbH, Olympus Europa SE & Co. KG, Olympus Finland OY, Olympus France, Olympus Hong Kong and China Limited, Olympus Imaging de México S.A. de C.V., Olympus Italia SRL, Olympus Korea Co. Ltd., Olympus Latin America Inc., Olympus Medical Equipment Services America Inc., Olympus Medical Products Czech spol. s r.o., Olympus Medical Systems India Private Limited, Olympus NDT Canada Inc., Olympus Nederland B.V., Olympus New Zealand Limited, Olympus Norge AS, Olympus Optical do Brasil Ltda, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc., Olympus Surgical & Industrial America Inc., Olympus Surgical Technologies America Inc, Olympus Sverige AB, Olympus Winter & Ibe Properties GmbH & Co. KG, Olympus doo Beograd, Om Digital Solutions Americas Inc, Quest Innovations B.V., Quest Medical Imaging B.V., Quest Photonic Devices B.V., SHIRAKAWA OLYMPUS CO. LTD., Spirus Medical Inc., TMEDIX CORPORATION., and Veran Medical Technologies Inc.. Read More

OTCMKTS:OCPNY

Olympus (OCPNY) Stock Price, News & Analysis

→ Top 10 AI Stocks to Buy Now (From TradingTips) (Ad)

Free OCPNY Stock Alerts

$18.00

-0.25 (-1.37%)

(As of 01/31/2023)

Compare

Today's Range: $18.00
▼
$18.00
50-Day Range: $18.00
▼
$18.00
52-Week Range: $16.80
▼
$74.99

Volume: 400 shs
Average Volume: 860,265 shs
Market Capitalization: $23.15 billion

P/E Ratio: 21.95
Dividend Yield: 0.44%
Price Target: N/A

Stock Analysis

Get Olympus alerts:

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

About Olympus Stock (OTCMKTS:OCPNY)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

OCPNY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OCPNY Stock News Headlines

May 11, 2023 | finance.yahoo.com

Tim Stroble Appointed as Olympus Insurance Company Chief Executive Officer

February 26, 2023 | bizjournals.com

New Olympus sports complex partnership is latest in $1B+ project's progress

February 23, 2023 | thestreet.com

Olympus Teams Up With Sony for Surgical Big Screen TV

January 12, 2023 | seekingalpha.com

Olympus says addressing FDA concerns on endoscope production

January 9, 2023 | finance.yahoo.com

Olympus Corporation (OCPNY) Stock Historical Prices & Data - Yahoo Finance

November 12, 2022 | seekingalpha.com

Olympus Corporation (OCPNY) Q3 2022 Earnings Call Transcript

October 21, 2022 | benzinga.com

Olympus Announces Leadership Succession Plan

October 9, 2022 | reuters.com

OCPNY.PK - | Stock Price & Latest News | Reuters

August 30, 2022 | finance.yahoo.com

What Makes Olympus Corp. (OCPNY) a Good Fit for "Trend Investing"

August 11, 2022 | finance.yahoo.com

Here's Why Momentum in Olympus Corp. (OCPNY) Should Keep going

August 9, 2022 | seekingalpha.com

Olympus Corporation (OCPNY) Management on Q1 2023 Results - Earnings Call Transcript

July 28, 2022 | finance.yahoo.com

Here's Why Olympus Corp. (OCPNY) is a Great Momentum Stock to Buy

April 23, 2022 | seekingalpha.com

ClearBridge Investments Global Growth Strategy Q1 2022 Commentary

April 14, 2022 | seekingalpha.com

ClearBridge International Growth ADR Strategy Portfolio Manager Commentary Q1 2022

February 3, 2022 | markets.businessinsider.com

Here's what to expect from Olympus's earnings

November 19, 2021 | finance.yahoo.com

Here's What Could Help Olympus Corp. (OCPNY) Maintain Its Recent Price Strength

November 16, 2021 | finance.yahoo.com

Olympus Corp. (OCPNY) Upgraded to Buy: Here's Why

November 13, 2021 | markets.businessinsider.com

Olympus Launches Venture Capital Fund To Strengthen Medtech Leadership

November 10, 2021 | markets.businessinsider.com

What Wall Street expects from OLYMPUS's earnings

November 8, 2021 | finance.yahoo.com

Thai Credit Retail Bank Weighing Bangkok IPO Next Year

November 5, 2021 | markets.businessinsider.com

Here's what Wall Street expects from Olympus's earnings

November 5, 2021 | nasdaq.com

Olympus Corp. Turns To Profit In H1, Lifts FY Outlook - Quick Facts

October 21, 2021 | finance.yahoo.com

Recent Price Trend in Olympus Corp. (OCPNY) is Your Friend, Here's Why

September 28, 2021 | finance.yahoo.com

Here's Why "Trend" Investors Would Love Betting on Olympus Corp. (OCPNY)

August 5, 2021 | markets.businessinsider.com

OLYMPUS earnings preview: what to expect

See More Headlines

Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/05/2021
Today: 6/11/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Structural clay products
Sub-Industry: N/A
Current Symbol: OTCMKTS:OCPNY
CUSIP: N/A
CIK: N/A
Web: www.olympus-global.com
Phone: (133) 340-2111
Fax: 813-3340-2062
Employees: 31,557
Year Founded: 1919

Profitability

EPS (Most Recent Fiscal Year): $0.82
Trailing P/E Ratio: 21.95
Forward P/E Ratio: 10.91
P/E Growth: 1.07
Net Income: $1.03 billion
Net Margins: 13.80%
Pretax Margin: N/A
Return on Equity: 24.30%
Return on Assets: 9.30%

Debt

Debt-to-Equity Ratio: 0.59
Current Ratio: 1.99
Quick Ratio: 1.48

Sales & Book Value

Annual Sales: $7.74 billion
Price / Sales: 2.99
Cash Flow: $1.22 per share
Price / Cash Flow: 14.76
Book Value: $3.50 per share
Price / Book: 5.14

Miscellaneous

Outstanding Shares: 1,285,890,000
Free Float: N/A
Market Cap: $23.15 billion
Optionable: Not Optionable
Beta: 0.70

Social Links

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Yasuo Takeuchi
President, Chief Executive Officer & Director
Nacho Abia
Chief Operating Officer
Chikashi Takeda
Chief Financial Officer
André Roggan
Executive Officer & Chief Technology Officer
Stephen Mark Kneebone
Chief Information Officer & Executive Officer

Key Competitors

View All Competitors

Should I Buy Olympus Stock? OCPNY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Olympus Co.:

Olympus Co. has recently launched a groundbreaking medical imaging device that is expected to revolutionize the healthcare industry. This innovative product is projected to significantly increase the company's revenue and market share in the medical technology sector.
The current stock price of Olympus Co. is showing a steady upward trend, indicating positive investor sentiment and potential for capital appreciation. This presents an attractive opportunity for investors looking for growth stocks.
Olympus Co. has successfully diversified its product portfolio to include cutting-edge consumer electronics, such as the latest Olympus OCPNY camera series. This strategic move has opened up new revenue streams and expanded the company's customer base.
The company's strong financial performance in recent quarters, with consistent revenue growth and healthy profit margins, demonstrates its resilience and ability to deliver value to shareholders. This stability makes Olympus Co. a reliable investment option for risk-averse investors.
Olympus Co. has a robust research and development department that continuously introduces innovative products to the market. This commitment to technological advancement ensures that the company stays competitive and relevant in rapidly evolving industries.

Cons

Investors should be bearish about investing in Olympus Co. for these reasons:

Olympus Co. faces intense competition from established industry players, which may limit its market share growth and put pressure on pricing strategies. This competitive landscape could impact the company's profitability and hinder its ability to maintain market leadership.
The global economic uncertainty and market volatility pose risks to Olympus Co.'s financial performance and stock price. External factors, such as geopolitical tensions or economic downturns, could negatively impact the company's operations and stock value.
Investing in Olympus Co. involves exposure to currency exchange rate fluctuations, especially if the company operates in multiple international markets. Foreign exchange risks can affect the company's revenue and profitability, leading to potential losses for investors.
Olympus Co. may face regulatory challenges and compliance issues in various jurisdictions where it operates. Changes in regulations or legal disputes could result in financial penalties, reputational damage, and operational disruptions for the company, affecting investor confidence.
The company's heavy reliance on a few key suppliers for critical components or materials could pose supply chain risks. Any disruptions in the supply chain due to unforeseen events like natural disasters or geopolitical issues may impact production schedules and revenue generation for Olympus Co.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 8, 2024. Please send any questions or comments about these Olympus pros and cons to contact@marketbeat.com.

OCPNY Stock Analysis - Frequently Asked Questions

How have OCPNY shares performed in 2024?: Olympus' stock was trading at $18.00 at the beginning of the year. Since then, OCPNY stock has increased by 0.0% and is now trading at $18.00.
View the best growth stocks for 2024 here.
How were Olympus' earnings last quarter?: Olympus Co. (OTCMKTS:OCPNY) posted its quarterly earnings results on Thursday, August, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.03. The company earned $1.75 billion during the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a net margin of 13.80% and a trailing twelve-month return on equity of 24.30%.
Is Olympus a good dividend stock?: Olympus (OTCMKTS:OCPNY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, OCPNY will have a dividend payout ratio of 9.20% next year. This indicates that the company will be able to sustain or increase its dividend.

How do I buy shares of Olympus?: Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Olympus have any subsidiaries?: The following companies are subsidiares of Olympus: AIZU OLYMPUS CORPORATION, ALGRAM GROUP LIMITED, AOMORI OLYMPUS CO. LTD., ARC MEDICAL DESIGN LIMITED, Advalytix AG, Arc Medical Design Limited, EVIDENT CORPORATION, EVIDENT NAGANO K.K., EVIDENT SCIENTIFIC SINGAPORE PTE. LTD., Evident Europe GmbH, Evident Europe GmbH - odštepný závod, Evident Europe GmbH Közvetlen Kereskedelmi Képviselete, Evident Europe GmbH Suomen sivuliike, Evident Korea Co. Ltd., Evident Scientific S. de R.L. de C.V., Evident Service Center Europe s.r.o., Evident Technology Center Europe GmbH, FH ORTHO, FH ORTHO SAS, FOURNITURES HOSPITALIERES INDUSTRIE, GYRUS MEDICAL LIMITED, Gyrus Acmi L.P., Gyrus Acmi LLC, Gyrus Ent L.L.C., Image Stream Medical Inc, Innov-X Systems Inc., KEYMED (IRELAND) LIMITED, KEYMED (MEDICAL & INDUSTRIAL EQUIPMENT) LIMITED, NAGANO OLYMPUS CO. LTD., OLIMPAS MOSKVA OOO, OLYMPUS (MALAYSIA) SDN. BHD., OLYMPUS (THAILAND) COMPANY LIMITED, OLYMPUS BUSINESS SERVICES SP Z O O, OLYMPUS DIGITAL SYSTEM DESIGN CORP., OLYMPUS ESTONIA OU, OLYMPUS EUROPA HOLDING SE, OLYMPUS GLOBAL TREASURY SERVICES LIMITED, OLYMPUS IBERIA SA., OLYMPUS IMAGING SINGAPORE PTE. LTD., OLYMPUS KEYMED GROUP LIMITED, OLYMPUS KEYMED INTERNATIONAL LIMITED, OLYMPUS MARKETING INC., OLYMPUS MEDICAL SYSTEMS CORP., OLYMPUS MEDICAL SYSTEMS VIETNAM CO. LTD, OLYMPUS OPTICAL TECHNOLOGY PHILIPPINES INC., OLYMPUS POLSKA SP Z O O, OLYMPUS SINGAPORE PTE. LTD., OLYMPUS SUPPORT MATE K.K., OLYMPUS TAIWAN CO. LTD., OLYMPUS TECHNOLOGIES SINGAPORE PTE LTD, OLYMPUS TERUMO BIOMATERIALS CORP., OLYMPUS VIET NAM COMPANY LIMITED, OLYMPUS Winter & Ibe GmbH, Olympus America Inc., Olympus América de México S.A. de C.V., Olympus Australia Pty Ltd, Olympus Austria Gesellschaft m.b.H., Olympus Belgium, Olympus Biotech Corporation, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group, Olympus Czech Group Podruznica Ljubljana, Olympus Czech Group s.r.o. Magyarországi Közvetlen Kereskedelmi Képviselete, Olympus Czech Group s.r.o. clen koncernu, Olympus Czech Group s.r.o. clen koncernu organizacná zložka, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Europa Management SE, Olympus Europa Property Management GmbH, Olympus Europa SE & Co. KG, Olympus Finland OY, Olympus France, Olympus Hong Kong and China Limited, Olympus Imaging de México S.A. de C.V., Olympus Italia SRL, Olympus Korea Co. Ltd., Olympus Latin America Inc., Olympus Medical Equipment Services America Inc., Olympus Medical Products Czech spol. s r.o., Olympus Medical Systems India Private Limited, Olympus NDT Canada Inc., Olympus Nederland B.V., Olympus New Zealand Limited, Olympus Norge AS, Olympus Optical do Brasil Ltda, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc., Olympus Surgical & Industrial America Inc., Olympus Surgical Technologies America Inc, Olympus Sverige AB, Olympus Winter & Ibe Properties GmbH & Co. KG, Olympus doo Beograd, Om Digital Solutions Americas Inc, Quest Innovations B.V., Quest Medical Imaging B.V., Quest Photonic Devices B.V., SHIRAKAWA OLYMPUS CO. LTD., Spirus Medical Inc., TMEDIX CORPORATION., and Veran Medical Technologies Inc..
Read More

This page (OTCMKTS:OCPNY) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial